Sym-012

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSym-012
Drug Alias Namerecombinant antibodies (Symphogen)receptor tyrosine kinase inhibitors (Symphogen)
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionNerve growth factor receptor Trk-A degraders
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSymphogen A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSymphogen A/S
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A